Rizvi Syed Ali-aamir — SEC Form 4 filings

SEC reporting owner CIK 1897621. 4 Form 4 filings on record with FilingPulse; latest filed 2026-02-13.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-04-03 to 2026-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ROCKET PHARMACEUTICALS, INC. (RCKT)Chief Medical Officer25
Poseida Therapeutics, Inc. (PSTX)Chief Medical Officer24

Form 4 filings — Rizvi Syed Ali-aamir

FiledFormIssuerReported transactionsSource
2026-02-134ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 61,963 @ $0 · Grant/award (A): 93,037 (derivative) @ $0EDGAR
2025-10-084ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 283,018 @ $0 · Grant/award (A): 62,893 @ $0 · Grant/award (A): 383,854 (derivative) @ $0EDGAR
2025-01-084Poseida Therapeutics, Inc. (PSTX)Code (U): 185,000 · Disposition to issuer (D): 250,000 (derivative) @ $0EDGAR
2024-04-034Poseida Therapeutics, Inc. (PSTX)Grant/award (A): 185,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1897621 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →